Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Funded Biomarker Testing

Find an overview of funded biomarker testing in Ontario. Information listed includes diagnostic, predictive and prognostic markers, as well as a summary of testing sites.

Disponible en anglais seulement. Vous pouvez demander un version française.

Funded Biomarker Testing

40 items

Reflex testing on newly diagnosed cases of NSCLC (adenocarcinoma/non-squamous).

Funded Biomarker Disease Site: Lung

Biomarker: PD-L1, ALK, EGFR, ROS1, BRAF, MET (Met Skipping), RET, FGFR1, HER2 (ERBB2), KRAS, PIK3CA, NTRK1, NTRK2, NTRK3 Optional for 22/23: NRG1, TP53, STK11, KEAP1

Testing Method:Panel

Testing Site: Hamilton Health Sciences, Health Sciences North, Kingston Health Sciences Centre, London Health Sciences Centre, St. Joseph's Healthcare Hamilton, Sunnybrook Health Sciences Centre, The Ottawa Hospital, Trillium Health Partners, University Health Network, William Osler Health System

Reflex testing on newly diagnosed cases of NSCLC (squamous).

Funded Biomarker Disease Site: Lung

Biomarker: PD-L1

Testing Method:Immunohistochemistry (IHC)

Reflex testing on newly diagnosed CD117 (cKIT) positive Gastrointestinal Stromal Tumours

Funded Biomarker Disease Site: Soft Tissue

Biomarker: BRAF, KIT, PDGFRA (Optional 23/24 - SDH, NTRK (fusion))

Testing Method:Sequencing

Testing Site: Hamilton Health Sciences, London Health Sciences Centre, Mount Sinai Hospital, St. Joseph's Healthcare Hamilton, Sunnybrook Health Sciences Centre, The Ottawa Hospital, University Health Network

Reflex testing on newly diagnosed epithelial and low malignant potential ovarian tumours.

Funded Biomarker Disease Site: Ovary

Biomarker: MLH1, MSH2, MSH6, PMS2

Testing Method:Immunohistochemistry (IHC)

Testing Site: Hamilton Health Sciences, Health Sciences North, Kingston Health Sciences Centre, London Health Sciences Centre, Markham Stouffville Hospital (Oak Valley Health), Mount Sinai Hospital, St. Joseph's Healthcare Hamilton, Sunnybrook Health Sciences Centre, The Ottawa Hospital, Trillium Health Partners, Unity Health - St. Michael's Hospital, University Health Network, William Osler Health System

Reflex testing on newly diagnosed gastric tumours when EBV associated adenocarcinoma is being considered.

Funded Biomarker Disease Site: Stomach

Biomarker: EBER

Testing Method:In Situ Hybridization (ISH)

Reflex testing on newly diagnosed invasive gastroesophageal adenocarcinomas.

Funded Biomarker Disease Site: Esophagus, Stomach

Biomarker: MLH1, MSH2, MSH6, PMS2, HER2

Testing Method:Immunohistochemistry (IHC)

Testing Site: Hamilton Health Sciences, Health Sciences North, Kingston Health Sciences Centre, London Health Sciences Centre, Mount Sinai Hospital, St. Joseph's Healthcare Hamilton, Sunnybrook Health Sciences Centre, The Ottawa Hospital, Unity Health - St. Michael's Hospital, University Health Network, William Osler Health System

Reflex testing on newly diagnosed sebaceous neoplasms.

Funded Biomarker Disease Site: Skin

Biomarker: MLH1, MSH2, MSH6, PMS2

Testing Method:Immunohistochemistry (IHC)

Reflex testing on newly diagnosed sebaceous tumours.

Funded Biomarker Disease Site: Ocular

Biomarker: MLH1, MSH2, MSH6, PMS2

Testing Method:Immunohistochemistry (IHC)

Testing Site: Hamilton Health Sciences, Health Sciences North, Kingston Health Sciences Centre, London Health Sciences Centre, Mount Sinai Hospital, St. Joseph's Healthcare Hamilton, Sunnybrook Health Sciences Centre, The Ottawa Hospital, Trillium Health Partners, Unity Health - St. Michael's Hospital, University Health Network, William Osler Health System

Reflex testing on newly diagnosed tumours with adrenal cortical carcinoma.

Funded Biomarker Disease Site: Adrenal Gland

Biomarker: MLH1, MSH2, MSH6, PMS2

Testing Method:Immunohistochemistry (IHC)

Testing Site: Hamilton Health Sciences, Kingston Health Sciences Centre, London Health Sciences Centre, Mount Sinai Hospital, St. Joseph's Healthcare Hamilton, Sunnybrook Health Sciences Centre, The Ottawa Hospital, Trillium Health Partners, University Health Network, William Osler Health System

Reflex testing on newly diagnosed tumours with advanced/metastatic prostate carcinoma.

Funded Biomarker Disease Site: Prostate

Biomarker: ATM, BRCA1, BRCA2, PALB2

Testing Method:Panel

Reflex testing on newly diagnosed tumours with advanced/metastatic prostate carcinoma.

Funded Biomarker Disease Site: Prostate

Biomarker: AR

Testing Method:Immunohistochemistry (IHC)

Reflex testing on newly diagnosed tumours with advanced/metastatic small bowel carcinoma.

Funded Biomarker Disease Site: Small Bowel

Biomarker: MLH1, MSH2, MSH6, PMS2

Testing Method:Immunohistochemistry (IHC)

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Funded Biomarker Testing

Funded Biomarker Testing

Reflex testing on newly diagnosed cases of NSCLC (adenocarcinoma/non-squamous).

Reflex testing on newly diagnosed cases of NSCLC (squamous).

Reflex testing on newly diagnosed CD117 (cKIT) positive Gastrointestinal Stromal Tumours

Reflex testing on newly diagnosed epithelial and low malignant potential ovarian tumours.

Reflex testing on newly diagnosed gastric tumours when EBV associated adenocarcinoma is being considered.

Reflex testing on newly diagnosed invasive gastroesophageal adenocarcinomas.

Reflex testing on newly diagnosed sebaceous neoplasms.

Reflex testing on newly diagnosed sebaceous tumours.

Reflex testing on newly diagnosed tumours with adrenal cortical carcinoma.

Reflex testing on newly diagnosed tumours with advanced/metastatic prostate carcinoma.

Reflex testing on newly diagnosed tumours with advanced/metastatic prostate carcinoma.

Reflex testing on newly diagnosed tumours with advanced/metastatic small bowel carcinoma.

Pages